PROBLEM??? Don't see one, unless having to wait is
Post# of 75002
The pps will bring them back into positive territory. Once that happens it'll keep climbing. When looking at capital gains over the 4 to 5 yr stretch (from 2015 on), then divided across that span, the equivalent annual capital gains would be sweet.
What sucks is when people plunk down short term cash on a momentum play that runs out of upward momentum and forces them into a long term hold. There were never massive revenues recorded that could offer strong support at those higher entry points.
That could have been realized if we had seen the explosion of progress we anticipated would come last year due to financing from Chinese investment, but it derailed.
Those of us who intended to hold the investment for years weren't placing such HUGE emphasis on fluctuations in the pennies anyhow, and just kept averaging down. I still am. I wasn't happy at all with the 2017 delay, but it's water under the bridge, and indeed we have a management team that's doing much more behind the scenes than people realize.
In due time, they will. When this company's progress goes exponential, we'll make huge gains. OTC investment is about speculation, and I agree, it's NOT for the faint of heart. Especially with start-up companies.
Bashers and those lacking confidence argue that after 3 years selling product a company isn't a start up any more. Bull shit they're not. Especially when they lose a year out of those 3 yrs. to an unfortunate derailment which sends them back 2 steps.
The important thing is they got right back on the horse, and got the financing they needed to re-launch the original brands along with a new ASS KICKING brand called HEMPd. The financing is a very non-toxic 12 million, not peanuts from toxic private investment deals.
If your bummed out because you're holding that bag, just hold it until you are out of the red then do what you have to do, but we should continue to see strong progress in that direction in the 2nd half of the year.